0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Medavail Holdings
Its shares trade under the ticker MDVLQ. It has been listed since 20 October 2008. In the fiscal year to 31 December 2022, it reported revenue of $43.1m and a net loss of $47.6m. At that date it held total assets of $33.1m and shareholders' equity of $20.8m.
MedAvail Holdings Inc is a US-based company operating in Consumer Staples Distribution & Retail industry. The company is headquartered in Phoenix, Arizona. The company went IPO on 2008-10-20. MedAvail Holdings, Inc. is a pharmacy technology and services company. The firm is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. The company operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 20 Oct 2008
- Employees
- 279
Leadership
Pay as last reported
- Mr. Robert FaulknerChairman of the Board, since 2020
- Mr. Mark DoerrPresident, Chief Executive Officer, Director, since 2022
- Ms. Ramona SeabaughChief Financial Officer, Treasurer, Company Secretary$823,100
- Mr. Steven HessExecutive Vice President and General Manager of SpotRx
- Gerald GradwellIndependent Director$272,982
- Mr. Paul JohnsonIndependent Director
- Dr. Michael KramerIndependent Director$282,982
- Ms. Laurie McgrawIndependent Director
- Dr. Glen StettinIndependent Director$265,982
- Ms. Caroline PaulInvestor Relations, since 2021
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 14
- Environment
- 15
- Social
- 15
- Governance
- 13
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The company operates a self-service pharmacy model via the MedCenter.
- It provides mobile applications and kiosks for patient interaction.
- Medicare patients are primarily serviced through its retail segment.
Weaknesses
- The firm is classified under Consumer Staples rather than Healthcare.
- It relies on third-party customers for technology sales.
- The business model depends on automated pharmacy technology.
Opportunities
- Direct sale of the MedCenter to healthcare providers is possible.
- Subscription models can be offered to large retail chains.
- Commercialization of the technology to systems presents growth.
Threats
- Competition exists among large retail pharmacy chains.
- Healthcare providers may develop internal automated solutions.
- Regulatory changes could impact pharmacy technology operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.